Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

January 15, 2026 - … announced the publication in npj Vaccines of data from a double-blind, placebo-controlled Phase 1 trial evaluating a … About the Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … announced the publication in npj Vaccines of data from a double-blind, placebo-controlled Phase 1 trial evaluating a …
News

Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program

November 5, 2025 - … 2b clinical program, Vaxart is conducting a randomized, double-blind, multi-center trial comparing its oral COVID-19 … 2b clinical program, Vaxart is conducting a randomized, double-blind, multi-center trial comparing its oral COVID-19 … 2b clinical program, Vaxart is conducting a randomized, double-blind, multi-center trial comparing its oral COVID-19 …
News

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

May 27, 2025 - … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

May 15, 2025 - … our clinical development program.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … our clinical development program.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … our clinical development program.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine

May 14, 2025 - … advances through clinical development. The single-center, double-blinded Phase 2b challenge study enrolled 165 healthy … advances through clinical development. The single-center, double-blinded Phase 2b challenge study enrolled 165 healthy … advances through clinical development. The single-center, double-blinded Phase 2b challenge study enrolled 165 healthy …
News

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

January 13, 2025 - … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

December 2, 2024 - … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need

October 15, 2024 - … $10.6 billion Presentation Information: Title: A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted … PT Room: 404 AB Title: A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging … $10.6 billion Presentation Information: Title: A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted …
News

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

September 30, 2024 - … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

June 13, 2024 - … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
Scroll to Top